| Exploring the curative potential of BCR-ABL1-targeting drugs for chronic myeloid leukaemia. | |
| | |
MedLine Citation:
|
PMID: 20965784 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Peter Valent |
Related Documents
:
|
12766384 - How to use nitrates. 21866794 - Formulation and evaluation of mucoadhesive matrix tablets of taro gum: optimization usi... 21849814 - Probe depth matters in dermal microdialysis sampling of benzoic acid after topical appl... 22005954 - Oxycellulose beads with drug exhibiting ph-dependent solubility. 17116504 - Pharmacological effects on sexual function. 20153414 - Sln for topical application in skin diseases--characterization of drug-carrier and carr... |
Publication Detail:
|
Type: Comment; Letter Date: 2010-10-19 |
Journal Detail:
|
Title: The lancet oncology Volume: 11 ISSN: 1474-5488 ISO Abbreviation: Lancet Oncol. Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-11-05 Completed Date: 2010-12-07 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100957246 Medline TA: Lancet Oncol Country: England |
Other Details:
|
Languages: eng Pagination: 1010-1 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents
/
administration & dosage* Drug Administration Schedule Fusion Proteins, bcr-abl / antagonists & inhibitors*, genetics Gene Expression Regulation, Leukemic Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*, enzymology, genetics, mortality Piperazines / administration & dosage Protein Kinase Inhibitors / administration & dosage* Pyrimidines / administration & dosage Recurrence Remission Induction Survival Rate Time Factors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents; 0/Fusion Proteins, bcr-abl; 0/Piperazines; 0/Protein Kinase Inhibitors; 0/Pyrimidines; 0/abl-bcr fusion protein, human; 152459-95-5/imatinib |
| Comments/Corrections | |
Comment On:
|
Lancet Oncol. 2010 Nov;11(11):1029-35
[PMID:
20965785
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The potential role of echocardiographic strain imaging for evaluating cardiotoxicity due to cancer t...
Next Document: Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete ...